Diabetes Clinical Trials in Miami

Showing 141-160 of 453 trials

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

NCT02580877

The study is a 2 arm, multi-center, randomized, open-labeled clinical trial designed to assess the effects of varying doses and schedules of oral insulin on immunological and metabolic markers in relatives at risk for type 1 diabetes (T1D).

Type 1 Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)92 participantsStarted Jan 2016

San Francisco, California, United States • Stanford, California, United States • Aurora, Colorado, United States +16 more locations

UNKNOWNNA< 1 mile

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

NCT03058029

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Assessing the Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects without or with Type 2 Diabetes

OverweightDiabetesPreDiabetes+1 more

Gelesis, Inc.300 participantsStarted Feb 2017

Birmingham, Alabama, United States • Bradenton, Florida, United States • Miami, Florida, United States +27 more locations

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

Diabetes Trials in Other Cities

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Rituximab in New Onset Type 1 Diabetes

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

Dose-ranging Study in Patients With Type 1 Diabetes Mellitus

Effects of Simulated Passive Jogging Device on Glucose Homeostasis, Muscle Strength and Endurance

Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes

Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

Patient and Provider Assessment of Lipid Management Registry

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Other Conditions in Miami